BPC-157 + TB-500 20mg (10 Vials / Kit)

BPC-157 / TB-500 Blend at a glance

Rather than a new molecule, this is a combination listing. One component is BPC-157, a synthetic fifteen-residue peptide taken from a gastric protein sequence. The other is TB-500, a synthetic peptide based on the actin-binding region of thymosin beta-4, a protein found in most cells. The two are freeze-dried together in a single vial, and the label should state the amount of each. The pairing reflects common research practice, not a combined product with its own data.

Price and availability

This is BioPepta‘s kit of 10 vials at 20mg each (200 mg in total), dispatched from China. The price is $162.90, or $0.815 per milligram of peptide. Of the 10 BPC-157 / TB-500 Blend listings on the marketplace, from 9 brands, this is the 2nd-lowest price per mg. Your payment waits in escrow until you confirm the parcel arrived, and only then is it released to the brand.

What it is studied for

Each component is studied for its own pathway. BPC-157 is associated in rodent and cell work with angiogenic signaling through VEGFR2, nitric oxide modulation and fibroblast migration, though its receptor remains unidentified. TB-500 is linked to the activity of thymosin beta-4, which sequesters G-actin and so influences how cells reorganize their cytoskeleton and move, with further reports on inflammatory signaling. Placing them in one vial does not create a new mechanism, and there is no established evidence that the two act together beyond what each does alone.

Research and regulatory status

Evidence for both peptides is preclinical, coming largely from rodent injury models and cell assays. Full-length thymosin beta-4 has been tested in small human trials for wound and eye conditions, but those results do not transfer automatically to the shorter TB-500 fragment. Studies of the combination itself are scarce. Neither peptide is approved as a medicine, and both appear on the World Anti-Doping Agency's prohibited list.

Checking the lab data

A blend report should identify both peptides separately. That means mass spectrometry showing two distinct masses, one for BPC-157 and one for the TB-500 sequence the vendor states, and an HPLC chromatogram with each main peak resolved and quantified. A single combined purity number tells you little. Ideally the report gives the measured content of each component against the label claim. The lyophilized cake should be white and uniform.

This listing has an independent lab report attached; the testing panel above summarises what the tested sample contained against its label.

Listing details

Compound

BPC-157 / TB-500 Blend

Synonyms

BPC-157 + Thymosin Beta-4 (TB-500)

Class

Dual-peptide research blend (gastric pentadecapeptide + actin-regulating peptide fragment)

Format

Lyophilized (freeze-dried) powder

Vial strength

20mg

Vials per kit

10

Total content

200 mg

Price per mg

$0.815

Sold by

BioPepta

Ships from

China

Lab report

Independent report attached

Storage and preparation

Keep unopened freeze-dried vials cold, sealed and out of the light; moisture is what degrades a lyophilized cake fastest. After reconstitution, refrigerate the solution and work within the stability window your protocol sets.

Concentration arithmetic: one 20 mg vial dissolved in 2 mL gives 10 mg/mL, or 20 mg/mL in 1 mL. The Research Lab calculator in your dashboard handles any other volume.

Buyer questions

Supplied for laboratory research only. Not for human or veterinary use, and not a substitute for any prescription medicine. Nothing on this page is medical advice.